home / stock / vrca / vrca news

VRCA News and Press, Verrica Pharmaceuticals Inc. From 02/05/24

Stock Information
Company Name: Verrica Pharmaceuticals Inc.
Stock Symbol: VRCA
Market: NASDAQ
Website: verrica.com
Menu
VRCA VRCA Quote VRCA Short VRCA News VRCA Articles VRCA Message Board
Get VRCA Alerts

News, Short Squeeze, Breakout and More Instantly...
VRCA - Verrica sues to keep unapproved catharidin drugs off US market

2024-02-05 10:53:46 ET More on Verrica Pharmaceuticals Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript Verrica Pharmaceuticals stock gains on Walgreens distribution deal Verrica stock rallies 55% amid positive Phase 3 results for skin drug ...
VRCA - Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH(TM) from Centers for Medicare and Medicaid Services

WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the Centers ...

VRCA - Verrica Pharmaceuticals: There Is A Silver Lining With YCANTH's Commercialization

2024-01-05 19:05:29 ET Summary Verrica Pharmaceuticals celebrates 5-year listing on Nasdaq after significant YoY rally and notable events, including FDA approval of VP-102 and debt financing agreement. Verrica's management is hopeful for the approval of VP-102 in Japan by end of 2...

VRCA - Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unmet need for new treatment options Company reiterates lesion clearance data from Part 2 of Phase 2 expected in Q2 2024 WEST CHESTER, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- V...
VRCA - Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH(TM) for the Treatment of Common Warts

WEST CHESTER, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it received ...

VRCA - Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH(TM)

WEST CHESTER, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it is growin...

VRCA - TTOO, CGEN and CLLS are among pre market gainers

2023-12-20 08:14:03 ET Polished ( POL ) +108% . Applied UV  ( AUVI ) +30% . Longeveron  ( LGVN ) +31% Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel- in the Treatment of Mild A...
VRCA - BLUE,XERS and CHRS are among after hour movers

2023-12-18 17:21:05 ET Gainers: Xeris Biopharma Holdings ( XERS ) +4% . Intuitive Machines ( LUNR ) +3% . Century Aluminum Company ( CENX ) +3% . Coherus BioSciences ( CHRS ) +2% . Independent Bank ( INDB ) +2% . Losers: ...

VRCA - BATL, SNCR and BVN are among pre market gainers

2023-12-18 08:17:02 ET Getaround ( GETR ) +85% . Battalion Oil Corp ( BATL ) +82% . Verrica Pharmaceuticals ( VRCA ) +62% . Cardio Diagnostics Holdings ( CDIO ) +45% . Brilliant Acquisition  ( BRLI ) +45% . Northann  ( ...

VRCA - Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today?

2023-12-15 13:49:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Verrica Pharmaceuticals (NASDAQ: VRCA ) skyrocketed on Friday thanks to positive late-stage clinical trial results. Specifically, Verrica — along with its developme...
Previous 10 Next 10